A disposable membrane oxygenator independently developed by a Shenzhen-based company has secured market access approval from the U.S. Food and Drug Administration, Xinhua reported yesterday. The device, developed by Chinabridge Shenzhen Medical Technology, is a critical disposable component of the Extracorporeal Membrane Oxygenation (ECMO) system — a kind of life support device for patients with life-threatening heart or lung failure. In 2023, the company’s ECMO made history as China’s first domestically developed device of its kind to receive market approval. To date, the product has obtained market access in over 40 countries and regions worldwide